ISHLT: The International Society for Heart & Lung Transplantation

Councils - Heart Failure and Transplant Medicine

SCIENTIFIC COUNCIL ON HEART FAILURE AND TRANSPLANT MEDICINE
COUNCIL LEADERSHIP	QUICK LINKS
CHAIRS	2013 HFTM COUNCIL MEETING Friday, April 26, 1:05 - 1:50 PM Room 513ABC, Palais des congrès de Montréal Council Report to the Board (PDF) LINKS NEWSLETTER December 2012 and September 2011 (PDF), focusing on Heart Failure & Transplant Medicine JOIN IN THE DISCUSSION! All ISHLT members with an interest in Heart Failure and Transplant Medicine are invited to join the ISHLT Heart Failure Support Discussion Group. Subscribers will be able to join a worldwide community of HF professionals. This group will cover all topics related to HF and only members will be able to post and view group content. We hope to make this the premier site to discuss difficult management issues, gaps in knowledge, or to tap into the expertise of your colleagues. To receive an invitation to join, please send an introductory email to our discussion group moderator, David Baran, at ishlt-hf@googlegroups.com - from your professional email address with credentials (name, professional title, affiliation and full contact information). Sorry, this group is not open to industry. The ISHLT HF google group home page is: http://groups.google.com/group/ishlt-hf
CHAIR José Tallaj, MD University of Alabama at Birmingham Birmingham, Alabama, USA 205-934-3438 jtallaj@uab.edu José A. Tallaj, MD, is an Associate Professor, Department of Internal Medicine, at the University of Alabama at Birmingham. He is a specialist in Cardiovascular Medicine, and his clinical interests are transplant cardiology, ventricular assist devices, congestive heart failure and pulmonary hypertension. Dr. Tallaj completed his medical degree at the Pontificia Universidad Catolica Madre y Maestra in Dominican Republic, and residency at Wayne State University in Detroit, Michigan. He completed a fellowship at the University of Alabama at Birmingham where he stayed on faculty. He is currently the Medical Director of the Heart Transplant program. VICE CHAIR: TBA PAST CHAIR David Brad Dyke, MD University of Michigan Ann Arbor, Michigan, USA 734-936-5265 DDyke@med.umich.edu David B. Dyke, MD, is an Associate Professor, Department of Internal Medicine, at the University of Michigan Health System. He is a specialist in Cardiovascular Medicine, and his clinical interests are transplant cardiology, ventricular assist devices, congestive heart failure and congenital heart disease. Dr. Dyke completed his medical degree and residency from the University of Michigan, as well as a fellowship in Cardiovascular Disease. Dr. Dyke's research interests include beta receptor physiology in patients with mitral valve disease, homocysteine metabolism in transplant patients, population science and research in transplant populations.
COMMITTEE REPRESENTATIVES
2014 ANNUAL MEETING PROGRAM COMMITTEE
Marisa Crespo-Leiro, MD Hospital Universitario A Coruña La Coruña, SPAIN 34-981-178-304 Marisa.Crespo.Leiro@sergas.es Maria G (Marisa) Crespo-Leiro, MD, PhD, FESC, is the Medical Director of the Advanced Heart Failure Transplant Unit at the Hospital Universitario A Coruña, La Coruña, Spain. She obtained her MD degree at the University of Santiago de Compostela, her specialization in cardiology at Clinica Puerta de Hierro in Madrid and her PhD from Universidad Autónoma de Madrid. Since 1993 she has been working in the Heart Division at the Hospital Universitario A Coruña (formerly the Hospital Universitario Juan Canalejo) in La Coruña, where she is also Associate Professor of Medicine. Her main fields of research interest are heart failure and heart transplantation. Göran Dellgren, MD Sahlgrenska University Hospital Goteborg, SWEDEN 46-31-342-88-63 goran.dellgren@vgregion.se Bio coming soon... Howard J. Eisen, MD, FAHA, FACC, FACP Drexel University College of Medicine and Hahnemann University Hospital Philadelphia, PA, USA 215-762-5080 Howard.Eisen@DrexelMed.edu Dr. Eisen obtained his MD from the University of Pennsylvania (UPenn) School of Medicine in 1981 where he was elected to Alpha Omega Alpha. He completed his internal medicine residency at the Hospital of UPenn (1981-1984), followed by a fellowship in cardiovascular medicine at Washington Univ in St. Louis and Barnes Hospital (1984-87) where he received training in the management of cardiac transplant recipients. He subsequently was on the faculty of UPenn School of Medicine and Temple Univ before joining the Drexel Univ College of Medicine and Hahnemann Univ Hospital as Chief of the Division of Cardiology in 2005. Dr. Eisen has been funded by the NIH to study microchimerism and cell adhesion molecule expression in cardiac transplant rejection and has played an important role in the investigation of gene expression profiling in cardiac transplantation. Dr. Eisen is board certified in Internal Medicine, Cardiovascular Diseases and Advanced Heart Failure and Transplant Cardiology by the American Board of Internal Medicine. David S. Feldman, MD, PhD Minneapolis Heart Institute Minneapolis, Minnesota, USA 612-863-3900 dfeldman@mplsheart.com Bio coming soon... Ashish S. Shah, MD Johns Hopkins Hospital Baltimore, Maryland, USA 410-502-3900 ashah29@csurg.jhmi.jhu.edu Bio coming soon... Michal Zakliczynski, MD Slaskie Centrum Chorb Serca Zabrze, POLAND 48-516-073-146 zaklimed@onet.pl Bio coming soon...
DEVELOPMENT COMMITTEE HFTM WORKFORCE LEADER
Robert C. Bourge, MD University of Alabama at Birmingham Birmingham, Alabama, USA 205-934-3624 bbourge@uab.edu Robert Bourge, MD, is Professor of Medicine, Radiology, and Surgery, the M. G. Waters Chair of Cardiovascular Disease, Director of the Division of Cardiovascular Disease, and Co-Director of the Heart and Vascular Research Center at the University of Alabama at Birmingham. His primary interest is in outcomes-research in advanced heart failure, heart and heart/lung transplantation, and pulmonary vascular disease. His clinical focus involves the evaluation of patients with these diseases and the subsequent application of therapeutic approaches including general, medical, device-based and surgical methods to improve both quality of life and life expectancy. Dr. Bourge received his MD from Louisiana State University Medical Center in New Orleans in 1979 where he received the Chancellor's award as the outstanding graduating medical student. He then completed a Residency in Internal Medicine, Fellowship in Cardiovascular Disease (serving as Chief Fellow in CV Disease from 1980-1982), and Fellowship in Nuclear Medicine at the University of Alabama at Birmingham (UAB) obtaining board certification in these three disciplines.
EDUCATION COMMITTEE HFTM WORKFORCE LEADER
David A. Baran, MD Newark Beth Israel Medical Center Newark, New Jersey, USA 973-926-7205 dbaran@sbhcs.com David Baran, MD, is the Director of Heart Failure and Transplant Research at Newark Beth Israel Medical Center in Newark, New Jersey. Dr. Baran graduated from the University of South Florida College of Medicine and completed his internal medicine residency at Columbia-Presbyterian Medical Center in New York City. His specialty training includes a congestive heart failure clinical/research fellowship both at Columbia Presbyterian Medical Center, as well as a clinical cardiology fellowhip at Mount Sinai Medical Center, New York City. Dr. Baran is board certified in internal medicine and cardiology and is certified by the United Network for Organ Sharing (UNOS) as a transplant cardiologist. He is a skilled invasive cardiologist with special competency in endomyocardial biopsy and diagnostic angiography. He has special interest in heart failure treatment trials and immunosuppression research.
I2C2 COMMITTEE HFTM WORKFORCE LEADER
Deborah E. Meyers, MD, FRACP, FACC Texas Heart Institute Houston, Texas, USA 832-355-9805 DMeyers@texasheart.org Deborah Meyers, MD is the Medical Director of Heart Failure Programs at Texas Heart Institute and St. Luke’s Episcopal Hospital in Houston, Texas. She is board certified in general cardiology and in advanced heart failure and transplantation. Dr. Meyers received her medical degree from the University of California, San Francisco School of Medicine where she also began her Internal Medicine residency. She completed her Cardiology Fellowship at Barnes-Jewish Hospital at Washington University in St. Louis. Dr. Meyers then traveled to Brisbane, Australia where she completed a post-graduate specialist training program at the University of Queensland, was awarded Fellowship in the Royal Australasian College of Physicians, and completed a fellowship in Heart Failure and Transplantation. In Australia, Dr. Meyers served as the Clinical Director of the Queensland Heart Failure & Transplantation Program and directed the Multidisciplinary Heart Failure Clinic at the Prince Charles Hospital in Chermside, Queensland. In 2008, she and her family returned to the United States. She continues to pursue her special interests in care delivery models, patient centered practice, medical decision making, the role of palliative services in heart failure, chronic disease management, and the relationship between physical activity and heart failure.
REGISTRIES & DATABASES COMMITTEE HFTM WORKFORCE LEADER
TBA
STANDARDS & GUIDELINES COMMITTEE HFTM WORKFORCE LEADER
Naveen Pereira, MD Mayo Clinic Rochester, Minnesota, USA 507-538-8151 pereira.naveen@mayo.edu Naveen Periera MD, FACC is a Consultant in Cardiovascular Diseases at Mayo Clinic, Rochester specializing in advanced heart failure, mechanical circulatory support and heart, heart-lung, heart-kidney and heart-liver transplantation. His research interests include investigating the role of surrogate markers of long-term mortality in heart transplantation including cardiac allograft hypertrophy, antibody mediated rejection and anti-HLA antibodies. He is NIH funded with a focus on genetic variation of the natriuretic peptide system and its effect on the pathophysiology and treatment response in heart failure. Dr. Pereira received his medical training at the University of Bombay, India. He completed his internal medicine residency at the University of Connecticut Health Sciences Center, Farmington, CT and cardiology fellowship at Brown University, Providence, RI and Massachusetts General Hospital, Boston, MA.
LIAISONS
BOARD OF DIRECTORS CO-LIAISONS
Maryl R. Johnson, MD University of Wisconsin Madison, WI, USA 608-263-0080 mrj@medicine.wisc.edu Bio coming soon... David O. Taylor, MD Cleveland Clinic Foundation Cleveland, Ohio, USA 216-444-2492 taylord2@ccf.org Dr. Taylor is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. Dr. Taylor is the Director of the Advanced Heart Failure and Transplant Cardiology Fellowship Program at Cleveland Clinic. Dr. Taylor completed his Internal Medicine residency, Cardiology fellowship, and Heart Failure/Transplant fellowship at the Medical College of Virginia in Richmond, Virginia. He remained on staff at MCV for one year prior to joining the U.T.A.H Cardiac Transplant Program in Salt Lake City in 1991. He moved to Cleveland Clinic in 2001.
BSTR COUNCIL CO-LIAISONS
Pradeep P.A. Mammen, MD, FACC, FAHA UT Southwestern Medical Center Dallas, Texas, USA 214-648-4994 pradeep.mammen@utsouthwestern.edu Bio coming soon... Uwe Schulz, MD Heart Center North-Rhine Westphalia Bad Oeynhausen, GERMANY 49-5731-973112 uwschulz@web.de Bio coming soon...
LINKS COMMUNICATIONS LIAISON
David P. Nelson, MD Integris Baptist Medical Center Oklahoma City, Oklahoma, USA 405-949-3349 david.nelson@integrisok.com Dr. David Nelson has been the Chief of Heart Transplant Medicine at the Nazih Zuhdi Transplant Institute at INTEGRIS Baptist Medical Center since 1994. He is a graduate of the Honors Program in Medical Education at Northwestern University in Chicago/Evanston, Illinois. He then completed his Internal Medicine Residency at Northwestern followed by a Pulmonary and Heart/Lung Transplant Fellowship at Stanford University, Palo Alto, California. He trained at Stanford under Dr. Norman Shumway, the “father of heart transplantation”. Dr. Nelson has been UNOS approved in both heart and lung transplantation. He was previously the Medical Director of Cardiac Transplantation at the Arizona Heart Institute and the Utah Cardiac Transplant Program, LDS Hospital. Under Dr. Nelson’s directorship, in 2002 the Nazih Zuhdi Transplant Institute set a benchmark with a 100% one-year survival rate and in 2003 the Heart and Lung Transplant Team was honored with the INTEGRIS Team Excellence Award.